Shtivelman E, Namikawa R
New Enterprise Research Division, Systemix Inc., Palo Alto, CA 94304, USA.
Proc Natl Acad Sci U S A. 1995 May 9;92(10):4661-5. doi: 10.1073/pnas.92.10.4661.
We have attempted to model human metastatic disease by implanting human target organs into the immunodeficient C.B-17 scid/scid (severe combined immunodeficiency; SCID) mouse, creating SCID-hu mice. Preferential metastasis to implants of human fetal lung and human fetal bone marrow occurred after i.v. injection of human small cell lung cancer (SCLC) cells into SCID-hu mice; the homologous mouse organs were spared. Clinically more aggressive variant SCLC cells metastasized more efficiently to human fetal lung implants than did cells from classic SCLC. Metastasis of variant SCLC to human fetal bone marrow was enhanced in SCID-hu mice exposed to gamma-irradiation or to interleukin 1 alpha. These data indicate that the SCID-hu mice may provide a model in which to study species- and tissue-specific steps of the human metastatic process.
我们试图通过将人类靶器官植入免疫缺陷的C.B-17 scid/scid(严重联合免疫缺陷;SCID)小鼠体内来模拟人类转移性疾病,从而创建SCID-hu小鼠。将人小细胞肺癌(SCLC)细胞静脉注射到SCID-hu小鼠体内后,会优先转移至人胎儿肺和人胎儿骨髓植入物;同源的小鼠器官则未受影响。临床上侵袭性更强的变异型SCLC细胞比经典SCLC细胞更有效地转移至人胎儿肺植入物。在接受γ射线照射或白细胞介素1α处理的SCID-hu小鼠中,变异型SCLC向人胎儿骨髓的转移增强。这些数据表明,SCID-hu小鼠可能提供了一个模型,用于研究人类转移过程中物种和组织特异性的步骤。